Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Farrelly

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Cancer Letters|July 1, 1985
Metabolic studies of 15N-labeled N-nitrosoproline in isolated rat hepatocytes and subcellular fractionsS R Koepke, Y Tondeur, J G Farrelly, et al.
Antisense Research and Development|January 1, 1994
Regulatory considerations for oligonucleotide drugs: updated recommendations for pharmacology and toxicology studiesL E Black, J G Farrelly, J A Cavagnaro, et al.
Clinical Pharmacology and Therapeutics|March 1, 1996
Response to Monro and Mehta proposal for use of single-dose toxicology studies to support single-dose studies of new drugs in humansJ Choudary, J F Contrera, A DeFelice, et al.
Toxicology Letters|January 22, 2000
Regulatory science: a special update from the United States Food and Drug Administration: Preclinical issues and status of investigation of botanical drug products in the United StatesK M Wu, J G DeGeorge, A Atrakchi, et al.
Physical Review Letters|July 26, 2014
Half-life systematics across the N=126 shell closure: role of first-forbidden transitions in the β decay of heavy neutron-rich nucleiA I Morales, J Benlliure, T Kurtukián-Nieto, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Cancer Letters|July 1, 1985
Metabolic studies of 15N-labeled N-nitrosoproline in isolated rat hepatocytes and subcellular fractionsS R Koepke, Y Tondeur, J G Farrelly, et al.
Antisense Research and Development|January 1, 1994
Regulatory considerations for oligonucleotide drugs: updated recommendations for pharmacology and toxicology studiesL E Black, J G Farrelly, J A Cavagnaro, et al.
Clinical Pharmacology and Therapeutics|March 1, 1996
Response to Monro and Mehta proposal for use of single-dose toxicology studies to support single-dose studies of new drugs in humansJ Choudary, J F Contrera, A DeFelice, et al.
Toxicology Letters|January 22, 2000
Regulatory science: a special update from the United States Food and Drug Administration: Preclinical issues and status of investigation of botanical drug products in the United StatesK M Wu, J G DeGeorge, A Atrakchi, et al.
Physical Review Letters|July 26, 2014
Half-life systematics across the N=126 shell closure: role of first-forbidden transitions in the β decay of heavy neutron-rich nucleiA I Morales, J Benlliure, T Kurtukián-Nieto, et al.
Pageof 4